🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of acetaminophen, alleging the corporations concealed alleged dangers that the pain reliever presented to pediatric brain development.

The court filing follows a month after President Donald Trump publicized an unverified association between taking acetaminophen - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "deceived the public by gaining financially from pain and promoting medication ignoring the risks."

The company asserts there is no credible evidence linking Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, knowingly endangering countless individuals to boost earnings," the attorney general, from the Republican party, said.

The manufacturer stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the well-being of US mothers and children."

On its official site, Kenvue also said it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a established connection between consuming paracetamol and autism spectrum disorder."

Associations speaking for doctors and health professionals agree.

ACOG has stated acetaminophen - the primary component in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and fever, which can pose significant medical dangers if ignored.

"In multiple decades of research on the use of paracetamol in gestation, no reliable research has definitively established that the consumption of acetaminophen in any stage of gestation causes neurological conditions in children," the group stated.

This legal action mentions current declarations from the previous government in asserting the medication is potentially dangerous.

Recently, Trump generated worry from medical authorities when he told expectant mothers to "struggle intensely" not to take acetaminophen when unwell.

Federal regulators then released a statement that medical professionals should contemplate reducing the use of acetaminophen, while also stating that "a causal relationship" between the medication and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in April to conduct "comprehensive study program" that would establish the source of autism in a limited time.

But experts cautioned that identifying a unique factor of autism - thought by researchers to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism is a type of permanent neurological difference and disability that influences how persons perceive and engage with the surroundings, and is diagnosed using doctors' observations.

In his court filing, Paxton - a Trump ally who is seeking federal office - alleges the manufacturer and J&J "willfully ignored and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the firms "eliminate any marketing or advertising" that states Tylenol is secure for women during pregnancy.

The court case echoes the grievances of a collection of parents of minors with autism and ADHD who took legal action against the makers of Tylenol in 2022.

Judicial authorities dismissed the legal action, saying studies from the plaintiffs' authorities was inconclusive.